Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A novel variant of interest of SARS-CoV-2 with multiple spike mutations detected through travel surveillance in Africa

View ORCID ProfileTulio de Oliveira, Silvia Lutucuta, John Nkengasong, Joana Morais, Joana Paula Paixão, Zoraima Neto, Pedro Afonso, Julio Miranda, Kumbelembe David, Luzia Inglês, Amilton Pereira Agostinho Paulo Raisa Rivas Carralero, Helga Reis Freitas, Franco Mufinda, Sofonias Kifle Tessema, Houriiyah Tegally, Emmanuel James San, Eduan Wilkinson, Jennifer Giandhari, Sureshnee Pillay, Marta Giovanetti, Yeshnee Naidoo, Aris Katzourakis, Mahan Ghafari, Lavanya Singh, Derek Tshiabuila, Darren Martin, View ORCID ProfileRichard J Lessells
doi: https://doi.org/10.1101/2021.03.30.21254323
Tulio de Oliveira
1KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tulio de Oliveira
  • For correspondence: deoliveira@ukzn.ac.za
Silvia Lutucuta
2Angola Ministry of Health, Luanda, Angola
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: deoliveira@ukzn.ac.za
John Nkengasong
3Africa Centres for Disease Control and Prevention (Africa CDC), Addis Ababa, Ethiopia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joana Morais
2Angola Ministry of Health, Luanda, Angola
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joana Paula Paixão
2Angola Ministry of Health, Luanda, Angola
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zoraima Neto
2Angola Ministry of Health, Luanda, Angola
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pedro Afonso
2Angola Ministry of Health, Luanda, Angola
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julio Miranda
2Angola Ministry of Health, Luanda, Angola
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kumbelembe David
2Angola Ministry of Health, Luanda, Angola
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luzia Inglês
2Angola Ministry of Health, Luanda, Angola
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amilton Pereira Agostinho Paulo Raisa Rivas Carralero
2Angola Ministry of Health, Luanda, Angola
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helga Reis Freitas
2Angola Ministry of Health, Luanda, Angola
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Franco Mufinda
2Angola Ministry of Health, Luanda, Angola
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sofonias Kifle Tessema
3Africa Centres for Disease Control and Prevention (Africa CDC), Addis Ababa, Ethiopia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Houriiyah Tegally
1KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emmanuel James San
1KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eduan Wilkinson
1KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Giandhari
1KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sureshnee Pillay
1KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Giovanetti
4Oswaldo Cruz Foundation (FioCruz), Rio de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yeshnee Naidoo
1KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aris Katzourakis
5University of Oxford, Oxford, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahan Ghafari
5University of Oxford, Oxford, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lavanya Singh
1KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Derek Tshiabuila
1KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darren Martin
6University of Cape Town, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard J Lessells
1KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Richard J Lessells
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

At the end of 2020, the Network for Genomic Surveillance in South Africa (NGS-SA) detected a SARS-CoV-2 variant of concern (VOC) in South Africa (501Y.V2 or PANGO lineage B.1.351)1. 501Y.V2 is associated with increased transmissibility and resistance to neutralizing antibodies elicited by natural infection and vaccination2,3. 501Y.V2 has since spread to over 50 countries around the world and has contributed to a significant resurgence of the epidemic in southern Africa. In order to rapidly characterize the spread of this and other emerging VOCs and variants of interest (VOIs), NGS-SA partnered with the Africa Centres for Disease Control and Prevention and the African Society of Laboratory Medicine through the Africa Pathogen Genomics Initiative to strengthen SARS-CoV-2 genomic surveillance across the region.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding for genomics surveillance was provided by the South African Medical Research Council (SAMRC), the South African Department of Science and Innovation (DSI), the Africa Centres for Disease Control and Prevention (Africa CDC) and the African Society of Laboratory Medicine (ASLM) through the Africa Pathogen Genomics Initiative (Africa PGI)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

he project was approved by University of KwaZulu-Natal Biomedical Research Ethics Committee. Protocol reference number: BREC/00001195/2020. Project title: COVID-19 transmission and natural history in KwaZulu-Natal, South Africa: Epidemiological Investigation to Guide Prevention and Clinical Care. Patient consent was not required for the genomic surveillance. This requirement was waived by the Research Ethics Committees.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All of the sequences are available at GISAID. All of the short reads are available at the Short Read Archive (SRA) of the National Centre for Biotechnology Information (NCBI) (Bioproject Accession: PRJNA717113).

https://www.krisp.org.za

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 04, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A novel variant of interest of SARS-CoV-2 with multiple spike mutations detected through travel surveillance in Africa
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A novel variant of interest of SARS-CoV-2 with multiple spike mutations detected through travel surveillance in Africa
Tulio de Oliveira, Silvia Lutucuta, John Nkengasong, Joana Morais, Joana Paula Paixão, Zoraima Neto, Pedro Afonso, Julio Miranda, Kumbelembe David, Luzia Inglês, Amilton Pereira Agostinho Paulo Raisa Rivas Carralero, Helga Reis Freitas, Franco Mufinda, Sofonias Kifle Tessema, Houriiyah Tegally, Emmanuel James San, Eduan Wilkinson, Jennifer Giandhari, Sureshnee Pillay, Marta Giovanetti, Yeshnee Naidoo, Aris Katzourakis, Mahan Ghafari, Lavanya Singh, Derek Tshiabuila, Darren Martin, Richard J Lessells
medRxiv 2021.03.30.21254323; doi: https://doi.org/10.1101/2021.03.30.21254323
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
A novel variant of interest of SARS-CoV-2 with multiple spike mutations detected through travel surveillance in Africa
Tulio de Oliveira, Silvia Lutucuta, John Nkengasong, Joana Morais, Joana Paula Paixão, Zoraima Neto, Pedro Afonso, Julio Miranda, Kumbelembe David, Luzia Inglês, Amilton Pereira Agostinho Paulo Raisa Rivas Carralero, Helga Reis Freitas, Franco Mufinda, Sofonias Kifle Tessema, Houriiyah Tegally, Emmanuel James San, Eduan Wilkinson, Jennifer Giandhari, Sureshnee Pillay, Marta Giovanetti, Yeshnee Naidoo, Aris Katzourakis, Mahan Ghafari, Lavanya Singh, Derek Tshiabuila, Darren Martin, Richard J Lessells
medRxiv 2021.03.30.21254323; doi: https://doi.org/10.1101/2021.03.30.21254323

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (175)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (171)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8794)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1864)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (493)
  • Hematology (207)
  • HIV/AIDS (396)
  • Infectious Diseases (except HIV/AIDS) (10575)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1762)
  • Nursing (104)
  • Nutrition (267)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (966)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (265)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (221)
  • Psychiatry and Clinical Psychology (1846)
  • Public and Global Health (3992)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (536)
  • Rheumatology (216)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (107)
  • Urology (80)